Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – The widely held view that maintenance treatment of stabilized patients with schizophrenia must be administered every day seems to be refuted by a…
NEW YORK (Reuters Health) – Patients with NYHA class I or II heart failure benefit from spironolactone therapy as well as those with class III or IV HF,…
NEW YORK (Reuters Health) – Children with acute diarrhea recover more quickly when treated with a hypotonic oral rehydration solution containing zinc and prebiotics than those given standard…
NEW YORK (Reuters Health) – The tyrosine-kinase inhibitor pazopanib seems to be a promising option for treating progressive metastatic differentiated thyroid cancer that is unresponsive to radioiodine therapy,…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…
NEW YORK (Reuters Health) – In children hospitalized with Henoch-Schönlein purpura, or HSP, corticosteroid treatment is associated with a decreased likelihood of several clinically relevant outcomes, according to…
NEW YORK (Reuters Health) – Response rates are higher when bortezomib plus dexamethasone rather than vincristine plus doxorubicin plus dexamethasone (VAD) is used as induction therapy before stem-cell…
NEW YORK (Reuters Health) – Using the rapid-acting insulin analog glulisine instead of regular human insulin at mealtimes improves glycemic control in hospitalized patients with type 2 diabetes,…
NEW YORK (Reuters Health) – The concern about proton pump inhibitors (PPIs) possibly interfering with the efficacy of clopidogrel may be misdirected, according to a new report. It…
NEW YORK (Reuters Health) – The antiplatelet effect of clopidogrel is much reduced in patients undergoing therapeutic hypothermia after cardiac arrest, according to a Norwegian study published online…
